Volume s1-29, Issue 3
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645


The authors recognize the need for a rapid acting parenteral antimalarial. Realizing that oral medication is the method of choice, there remains, however, many instances in which it is difficult or impossible for the patient to take drugs by mouth. Among these, we might mention the mental patient who is violent or contrary, the patient in coma suffering from pernicious malaria, or the patient who is vomiting.

Camoquin Hydrochloride , (SN 10751), a new synthetic antimalarial, has been studied in order to determine its possibilities as a successful antimalarial for parenteral use. It is chemically known as 4(3′-diethylamino-methyl-4′-hydroxyanilino)-7-chloroquinoline dihydrochloride dihydrate. In crystalline form, it is light yellow in color and soluble in water in a 5 per cent concentration at room temperature. The synthesis of this drug was first reported at a meeting of the American Chemical Society in 1946 (1).

Various workers have checked the effectiveness of this drug against avian malaria.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error